Vivos Inc (RDGL)

[Roofus]

I think you're being very conservative with that dollar amount

If the FDA approves this, and any announcement on how this is advancing to human trials, will shoot this past $5.00, easily.

If it passes relevant testing during human trials, and gets approved to be treated on humans, then this technology goes to the moon.

Possibly $25.00 - $50.00 or more, per share.
The technology would be worth many billions, tens of billions probably.
Remember, this can be used on at least 18 different types of cancer "worldwide".
Divide that market cap value (let's say $10 billion) by the current OS (currently at 235 million shares).

But just getting to human trials = we're very rich.

I think George Sharp, and Dr. Korenko already know that this is almost certainly going to human trials soon, at the very least.